In this retrospective study, we analyzed data in The Cancer Genome Atlas (TCGA) Pan-Cancer Atlas for ER expression and downstream signaling activity in breast, ovarian, endometrial, and cervical cancer patients to elucidate the differences in ER cell signaling and survival among these four cancers [25, 26]. The gene discussed is ESR1; the disease is cervical cancer.